Skip to main content
Top
Published in: International Urology and Nephrology 9/2019

01-09-2019 | Erectile Dysfunction | Urology - Original Paper

Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with vascular erectile dysfunction: a comparative randomized prospective study

Authors: Zeki Bayraktar, Selami Albayrak

Published in: International Urology and Nephrology | Issue 9/2019

Login to get access

Abstract

Purpose

We aimed to investigate the efficacy and safety of tadalafil, aspirin, and tadalafil + aspirin combination therapy in vascular erectile dysfunction (VED).

Methods

A total of 336 patients were randomly divided into four groups (group 1, aspirin 100 mg/day, 126 patients; group 2, tadalafil 5 mg/day, 72 patients; group 3, tadalafil 5 mg + aspirin 100 mg, 72 patients; group 4, placebo, 66 patients). In all groups, the changes from baseline to end point in erectile function scores on the International Index of Erectile Function (IIEF-EF) and the number of patients who answered “yes” to questions 2 and 3 of the sexual encounter profile(SEP) were compared statistically.

Results

The changes in IIEF-EF scores after treatment were 7.2 ± 4.4, 7.3 ± 4.3, 7.5 ± 4.4, and 2.0 ± 4.6 for group 1 (p < 0.0001), group 2 (p < 0.0001), group 3 (p < 0.0001), and group 4 (p = 0.0204), respectively. The change in SEP-2 ratios after treatment were 36.6%, 36.9%, 41.7%, and 9.4% for group 1 (p < 0.0001), group 2 (p < 0.0001), group 3 (p < 0.0001), and group 4 (p = 0.2925), respectively. The change in SEP-3 ratios after treatment was 46.6%, 49.2%, 53.7%, and 12.5% for group 1 (p < 0.0001), group 2 (p < 0.0001), group 3 (p < 0.0001), and group 4 (p = 0.1456), respectively. In group 2, both the number of patients who reported side effects (p < 0.0001) and stopped using the drug due to side effects (p < 0.05) were significantly higher than the control and others groups.

Conclusions

Successful results were obtained by tadalafil and aspirin monotherapy and tadalafil + aspirin combination therapy in patients with VED. However, the least side effect was observed in the tadalafil + aspirin group. Aspirin can be used alone in the treatment of patients with VED, or combined with tadalafil to reduce side effects and increase success.
Literature
2.
go back to reference Kulkarni SS, Patil CS (2004) Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects. Methods Find Exp Clin Pharmacol 26:789–799CrossRefPubMed Kulkarni SS, Patil CS (2004) Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects. Methods Find Exp Clin Pharmacol 26:789–799CrossRefPubMed
4.
go back to reference Brock GB, McMahon CG, Chen KK et al (2002) Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 168:1332–1336CrossRefPubMed Brock GB, McMahon CG, Chen KK et al (2002) Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 168:1332–1336CrossRefPubMed
5.
go back to reference Montorsi F, Verheyden B, Meuleman E et al (2004) Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction. Eur Urol 45:339–345CrossRefPubMed Montorsi F, Verheyden B, Meuleman E et al (2004) Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction. Eur Urol 45:339–345CrossRefPubMed
6.
go back to reference Eardley I, Donatucci C, Corbin J et al (2010) Pharmacotherapy for erectile dysfunction. J Sex Med 7:524–540CrossRefPubMed Eardley I, Donatucci C, Corbin J et al (2010) Pharmacotherapy for erectile dysfunction. J Sex Med 7:524–540CrossRefPubMed
7.
go back to reference Rajfer J, Aliotta PJ, Steidle CP, Fitch WP III, Zhao Y, Yu A (2007) Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res 19:95–103CrossRefPubMed Rajfer J, Aliotta PJ, Steidle CP, Fitch WP III, Zhao Y, Yu A (2007) Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res 19:95–103CrossRefPubMed
8.
9.
go back to reference Bayraktar Z, Albayrak S (2017) Blood platelet activity in men with vasculogenic erectile dysfunction. Arch Ital Urol Androl 89(1):51–54CrossRefPubMed Bayraktar Z, Albayrak S (2017) Blood platelet activity in men with vasculogenic erectile dysfunction. Arch Ital Urol Androl 89(1):51–54CrossRefPubMed
14.
go back to reference Otunctemur A, Bozkurt M, Besiroglu H, Polat EC, Ozcan L, Ozbek E (2015) Erectile dysfunction is positively correlated with mean platelet volume and platelet count, but not with eosinophil count in peripheral blood. Urol J. 12(5):2347–2352PubMed Otunctemur A, Bozkurt M, Besiroglu H, Polat EC, Ozcan L, Ozbek E (2015) Erectile dysfunction is positively correlated with mean platelet volume and platelet count, but not with eosinophil count in peripheral blood. Urol J. 12(5):2347–2352PubMed
17.
go back to reference Sönmez MG, Göğer YE, Sönmez LÖ, Aydın A, Balasar M, Kara C (2016) Can eosinophil count, platelet count, and mean platelet volume be a positive predictive factor in penile arteriogenic erectile dysfunction etiopathogenesis? Am J Mens Health (pii: 1557988316679575. Epub ahead of print) Sönmez MG, Göğer YE, Sönmez LÖ, Aydın A, Balasar M, Kara C (2016) Can eosinophil count, platelet count, and mean platelet volume be a positive predictive factor in penile arteriogenic erectile dysfunction etiopathogenesis? Am J Mens Health (pii: 1557988316679575. Epub ahead of print)
19.
go back to reference Dong JY, Zhang YH, Qin LQ (2011) Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 58:1378–1385CrossRefPubMed Dong JY, Zhang YH, Qin LQ (2011) Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 58:1378–1385CrossRefPubMed
22.
go back to reference Endler G, Klimesch A, Sunder-Plassmann H et al (2002) Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117:399–404CrossRefPubMed Endler G, Klimesch A, Sunder-Plassmann H et al (2002) Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117:399–404CrossRefPubMed
23.
go back to reference Rosen RC, Cappelleri JC, Gendrano N III (2002) The international index of erectile function (IIEF): a state-of-the-science review. Int J Impot Res 14(4):226–244CrossRefPubMed Rosen RC, Cappelleri JC, Gendrano N III (2002) The international index of erectile function (IIEF): a state-of-the-science review. Int J Impot Res 14(4):226–244CrossRefPubMed
24.
go back to reference Rosen RC, Allen KR, Ni X, Araujo AB (2011) Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol 60(5):1010–1016CrossRefPubMed Rosen RC, Allen KR, Ni X, Araujo AB (2011) Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol 60(5):1010–1016CrossRefPubMed
25.
go back to reference Carson CC, Rajfer J, Eardley I et al (2004) The efficacy and safety of tadalafil: an update. BJU Int 93(9):1276–1281CrossRefPubMed Carson CC, Rajfer J, Eardley I et al (2004) The efficacy and safety of tadalafil: an update. BJU Int 93(9):1276–1281CrossRefPubMed
26.
go back to reference Toda N, Ayajiki K, Okamura T (2005) Nitric oxide and penile erectile function. Pharmacol Ther 106(2):233–266CrossRefPubMed Toda N, Ayajiki K, Okamura T (2005) Nitric oxide and penile erectile function. Pharmacol Ther 106(2):233–266CrossRefPubMed
27.
go back to reference Furuno T, Yamasaki F, Yokoyama T et al (2011) Effects of various doses of aspirin on platelet activity and endothelial function. Heart Vessels 26(3):267–273CrossRefPubMed Furuno T, Yamasaki F, Yokoyama T et al (2011) Effects of various doses of aspirin on platelet activity and endothelial function. Heart Vessels 26(3):267–273CrossRefPubMed
29.
go back to reference Buvat J, Büttner H, Hatzimouratidis K et al (2013) Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafilonce a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction. J Sex Med 10(6):1592–1602. https://doi.org/10.1111/jsm.12130 (Epub 2013 Apr 2) CrossRefPubMed Buvat J, Büttner H, Hatzimouratidis K et al (2013) Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafilonce a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction. J Sex Med 10(6):1592–1602. https://​doi.​org/​10.​1111/​jsm.​12130 (Epub 2013 Apr 2) CrossRefPubMed
30.
go back to reference Rajfer J, Aliotta PJ, Steidle CP et al (2007) Tadalafil dosed once a day men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res 19(1):95–103 (Epub 2006 Jul 27) CrossRefPubMed Rajfer J, Aliotta PJ, Steidle CP et al (2007) Tadalafil dosed once a day men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res 19(1):95–103 (Epub 2006 Jul 27) CrossRefPubMed
31.
go back to reference Hafez G, Gonulalan U, Kosan M et al (2014) Acetylsalicylic acid protects erectile function in diabetic rats. Andrologia 46(9):997–1003CrossRefPubMed Hafez G, Gonulalan U, Kosan M et al (2014) Acetylsalicylic acid protects erectile function in diabetic rats. Andrologia 46(9):997–1003CrossRefPubMed
32.
go back to reference Tauseef M, Shahid M, Sharma KK, Fahim M (2008) Antioxidative action of aspirin on endothelial function in hypercholesterolaemic rats. Basic Clin Pharmacol Toxicol 03(4):314–321CrossRef Tauseef M, Shahid M, Sharma KK, Fahim M (2008) Antioxidative action of aspirin on endothelial function in hypercholesterolaemic rats. Basic Clin Pharmacol Toxicol 03(4):314–321CrossRef
33.
go back to reference Argiolas A, Melis MR, Stancampiano R, Gessa GL (1990) Oxytocin-induced penile erection and yawning: role of calcium and prostaglandins. Pharmacol Biochem Behav 35(3):601–605CrossRefPubMed Argiolas A, Melis MR, Stancampiano R, Gessa GL (1990) Oxytocin-induced penile erection and yawning: role of calcium and prostaglandins. Pharmacol Biochem Behav 35(3):601–605CrossRefPubMed
34.
go back to reference Bornman MS, Dormehl IC, Franz RC, Du Plessis DJ, Jacobs DJ (1986) Platelets and thromboxane A2 in the pathogenesis of aging penile vascular changes and impotence. Arch Androl 17(3):233–234CrossRefPubMed Bornman MS, Dormehl IC, Franz RC, Du Plessis DJ, Jacobs DJ (1986) Platelets and thromboxane A2 in the pathogenesis of aging penile vascular changes and impotence. Arch Androl 17(3):233–234CrossRefPubMed
35.
go back to reference Bornman MS, Dormehl IC, Du Plessis DJ, Du Plessis M, Jacobs DJ, Maree M (1986) Entrapment of platelets in the penis during and after erection. S Afr Med J 69(8):500–501PubMed Bornman MS, Dormehl IC, Du Plessis DJ, Du Plessis M, Jacobs DJ, Maree M (1986) Entrapment of platelets in the penis during and after erection. S Afr Med J 69(8):500–501PubMed
36.
go back to reference Elnazer HY, Sampson A, Baldwin D (2015) Lithium and sexual dysfunction: an under-researched area. Hum Psychopharmacol 30(2):66–69CrossRefPubMed Elnazer HY, Sampson A, Baldwin D (2015) Lithium and sexual dysfunction: an under-researched area. Hum Psychopharmacol 30(2):66–69CrossRefPubMed
37.
go back to reference Israilov S, Baniel J, Shmueli J et al (2004) Treatment program for erectile dysfunction in patients with cardiovascular diseases. Am J Cardiol 93(6):689–693CrossRefPubMed Israilov S, Baniel J, Shmueli J et al (2004) Treatment program for erectile dysfunction in patients with cardiovascular diseases. Am J Cardiol 93(6):689–693CrossRefPubMed
38.
go back to reference Saroukhani S, Emami-Parsa M, Modabbernia A et al (2013) Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study. Bipolar Disord 15(6):650–656CrossRefPubMed Saroukhani S, Emami-Parsa M, Modabbernia A et al (2013) Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study. Bipolar Disord 15(6):650–656CrossRefPubMed
40.
go back to reference Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G (2007) Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res 19:200–207CrossRefPubMed Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G (2007) Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res 19:200–207CrossRefPubMed
Metadata
Title
Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with vascular erectile dysfunction: a comparative randomized prospective study
Authors
Zeki Bayraktar
Selami Albayrak
Publication date
01-09-2019
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 9/2019
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-019-02211-4

Other articles of this Issue 9/2019

International Urology and Nephrology 9/2019 Go to the issue